Pubertal height gain in Ullrich-Turner syndrome

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 8, 2006, Pages 987-993

  Bechtold, Susanne ^a   Dalla Pozza, R ^a   Schmidt, H ^a   Bonfig, W ^a   Schwarz, H P ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Final height; Growth hormone; Puberty; Short stature; Ullrich Turner syndrome

Indexed keywords

GROWTH HORMONE; OXANDROLONE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; EARLY INTERVENTION; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PUBERTY; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TURNER SYNDROME;

EID: 33748450070     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.8.987     Document Type: Article

References (24)

1. Hook EB, Warburton D. The distribution of chromosomal genotypes associated with Turner's syndrome: live birth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet 1983; 64: 24-27.
2. Ranke MB, Stubbe P, Majewski F, Bierich JR. Spontaneous growth in Turner's syndrome. Acta Paediatr Scand 1988; Suppl 343: 22-30.
3. Quigley CA, Crowe BJ, Anglin G, Chipman JJ. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 2002; 87: 2033-2041.
4. Van Pareren YK, De Muick Keizer-Schrama SMPF, Stijnen T, Sas TCJ, Jansen M, Otten BJ, Hoorweg-Nijman JJG, Vulsma T, Stovis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rogen-Westlaken C, Drop SLS. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003; 88: 1119-1125.
5. Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. J Clin Endocrinol Metab 2000; 85: 2439-2445.
6. Cacciari E, Mazzanti L. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. J Clin Endocrinol Metab 1999; 84: 4510-4515.
7. Reiter EO, Blethen SL, Baptista J, Price L. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome. J Clin Endocrinol Metab 2001; 86: 1936-1941.
8. Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab 1998; 83: 1462-1466.
9. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hulterantz M, Landin-Wilhelmsen K, Lin A, Lippe B, Pasquino AM, Ranke MB, Rosenfeld R, Silberbach M. Recommendations for diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001; 86: 3061-3069.
10. Saenger P. Growth-promoting strategies in Turner's syndrome. J Clin Endocrinol Metab 1999; 84: 4345-4348.
11. Brook CGD. Turner syndrome. Arch Dis Child 1986; 61: 305-309.
12. Tanner JM. Growth at Adolescence, 2nd Ed. Oxford: Blackwell, 1962.
13. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd Ed. Palo Alto, CA: Stanford University Press, 1959.
14. Ranke MB, Partsch CJ, Lindberg A, Dörr HG, Bettendorf M, Hauffa BP, Schwarz HP, Mehls O, Sander A, Stahnke N, Steinkamp H, Said E, Sippell W. Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU follow-up study 2001. Eur J Endocrinol 2002; 147: 625-633.
15. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA. Predicting of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. J Clin Endocrinol Metab 2000; 85: 4212-4218.
16. Ranke MB, Haug F, Blum WF, Rosendahl W, Attanasio A, Bierich JR. Effect on growth of patients with Turner's syndrome treated with low estrogen doses. Acta Endocrinol Copenh 1986; Suppl 279: 153-156.
17. Gault EJ, Paterson WF, Young D, Donaldson MDC. Improved final height in Turner's syndrome following growth-promoting treatment at a single center. Acta Paediatr 2003; 92: 1033-1038.
18. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner's syndrome. J Clin Endocrinol Metab 1997; 82: 1810-1813.
19. Apter D, Lenko HL, Perheentupa J, Söderholm A, Vihko R. Subnormal pubertal increases of serum androgens in Turner's syndrome. Horm Res 1982; 16: 164-173.
20. Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Karlberg J, Kriström B, Marcus C, Moell C, Ritzén M, Tuvemo T, Wattsgård C, Westgre U, Westphal O, Åman J. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 1996; 81: 635-640.
21. Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 1998; 132: 319-324.
22. Sas TCJ, De Muinck Keizer-Schrama SMPF, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJG, Vulsma T, Massa GG, Rouwé CW, Reeser M, Gerver WJ, Gosen JJ, Rongen-Westlaken C, Drop SLS. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J Clin Endocrinol Metab 1999; 84: 4607-4612.
23. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child 1985; 60: 932-935.
24. Massa G, Heinrichs C, Verlinde S, Thomas M, Bourguignon JP, Craen M, Francois I, Du Caju M, Maes M, De Schepper J. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height. J Clin Endocrinol Metab 2003; 88: 4168-4174.